User profiles for Rachel E Heap
Rachel Peltier-HeapGlaxosmithkline Verified email at gsk.com Cited by 259 |
Proteomics characterisation of the L929 cell supernatant and its role in BMDM differentiation
BMDMs are a key model system to study macrophage biology in vitro. Commonly used
methods to differentiate macrophages from BM are treatment with either recombinant M-CSF or …
methods to differentiate macrophages from BM are treatment with either recombinant M-CSF or …
[HTML][HTML] A direct-to-biology high-throughput chemistry approach to reactive fragment screening
RP Thomas, RE Heap, F Zappacosta, EK Grant… - Chemical …, 2021 - pubs.rsc.org
Methods for rapid identification of chemical tools are essential for the validation of emerging
targets and to provide medicinal chemistry starting points for the development of new …
targets and to provide medicinal chemistry starting points for the development of new …
Identifying inhibitors of inflammation: a novel high-throughput MALDI-TOF screening assay for salt-inducible kinases (SIKs)
RE Heap, AG Hope, LA Pearson… - … Life Sciences R&D, 2017 - journals.sagepub.com
Matrix-assisted laser desorption/ionization time-of-flight (MALDI TOF) mass spectrometry
has become a promising alternative for high-throughput drug discovery as new instruments …
has become a promising alternative for high-throughput drug discovery as new instruments …
Mass spectrometry techniques for studying the ubiquitin system
RE Heap, MS Gant, F Lamoliatte… - Biochemical Society …, 2017 - portlandpress.com
Post-translational control of proteins through covalent attachment of ubiquitin plays important
roles in all eukaryotic cell functions. The ubiquitin system in humans consists of 2 E1, 35 E2 …
roles in all eukaryotic cell functions. The ubiquitin system in humans consists of 2 E1, 35 E2 …
[HTML][HTML] Profiling embryonic stem cell differentiation by MALDI TOF mass spectrometry: development of a reproducible and robust sample preparation workflow
MALDI TOF mass spectrometry (MS) is widely used to characterise and biotype bacterial
samples, but a complementary method for profiling of mammalian cells is still underdeveloped. …
samples, but a complementary method for profiling of mammalian cells is still underdeveloped. …
Advances in high‐throughput mass spectrometry in drug discovery
ME Dueñas, RE Peltier‐Heap, M Leveridge… - EMBO Molecular …, 2023 - embopress.org
High‐throughput (HT) screening drug discovery, during which thousands or millions of
compounds are screened, remains the key methodology for identifying active chemical matter in …
compounds are screened, remains the key methodology for identifying active chemical matter in …
[PDF][PDF] A chemoproteomic platform for selective deubiquitinase inhibitor discovery
…, CR Kennedy, JM Kirkpatrick, RE Peltier-Heap… - Cell Reports Physical …, 2023 - cell.com
Chemoproteomics is a powerful method capable of detecting interactions between small
molecules and the proteome; however, its use as a high-throughput screening method for …
molecules and the proteome; however, its use as a high-throughput screening method for …
[HTML][HTML] A high-throughput MALDI-TOF MS biochemical screen for small molecule inhibitors of the antigen aminopeptidase ERAP1
MALDI-TOF MS is a powerful analytical technique that provides a fast and label-free readout
for in vitro assays in the high-throughput screening (HTS) environment. Here, we describe …
for in vitro assays in the high-throughput screening (HTS) environment. Here, we describe …
A Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Assay Identifies Nilotinib as an Inhibitor of Inflammation in Acute Myeloid Leukemia
JL Marin-Rubio, RE Peltier-Heap… - Journal of Medicinal …, 2022 - ACS Publications
Inflammatory responses are important in cancer, particularly in the context of monocyte-rich
aggressive myeloid neoplasm. We developed a label-free cellular phenotypic drug discovery …
aggressive myeloid neoplasm. We developed a label-free cellular phenotypic drug discovery …
A MALDI-TOF assay identifies nilotinib as an inhibitor of inflammation in acute myeloid leukaemia
Inflammatory responses are important in cancer, particularly in the context of monocyte-rich
aggressive myeloid neoplasm. We developed a label-free cellular phenotypic drug discovery …
aggressive myeloid neoplasm. We developed a label-free cellular phenotypic drug discovery …